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Background: Cardiac catheterization (CC) is an important diagnostic and therapeutic procedure for congenital heart disease (CHD). IMPACT 
Registry was developed to track variation and support quality measurement in CHD.
Methods: IMPACT Registry is multi-center and inclusive, and collects patient and procedural characteristics, including details on 6 intervention 
types, and outcome data on adult and pediatric patients with CHD. Rate of major adverse events (AE) and/or death (<30 days after CC) are reported 
stratified by age group.
Results: During the first 2 Quarters of 2011 there were 1391 records submitted on 1235 patients by 13 centers. 
Age Group Total Cohort Major AE or Death
(n=1235) (n=36)
Neonate (<1m) 91 (7%) 18 (25%)
Infant (1y) 219 (18%) 11 (7%)
Children 752 (61%) 6 (1%)
Adult (>18y) 173 (14%) 1 (1%)
Major AE rates included: arrhythmia requiring temporary or permanent pacemaker, n= 5 (0.4%), unplanned cardiac surgery due to CC, n=3 (0.2%), 
cardiac arrest n=19 (1.6%) and death within 30 days of CC, n=28 (2.3%). AE were more common in neonates (Table). Specific interventions included 
ASD closure 119 (8.6%), PDA closure 140 (10.1%), Coarctation therapy 60 (4.3%), Valvar AS 22 (1.6%), Valvar PS 27 (1.9%) and PA stent 41 (2.9%). 
The remaining 982 (70.6%) procedures were diagnostic CC and/or other interventions.
Conclusions: IMPACT allows tracking of CC procedure types and outcomes in CHD. Major AE rates are higher in neonates. Collaborative 
participation will facilitate improvements in the care of patients with CHD.
